Antonino Romano, MD; Marinella Viola, MD; Rosa-Maria Guéant-Rodriguez, MD; Francesco Gaeta, MD; Rocco Valluzzi, MD; Jean-Louis Guéant, MD, PhD
Grant Support: By the Italian Ministry for University, Scientific and Technological Research (MURST) and the French Ministry for National Education, Research and Technology (MENRT).
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Antonino Romano, MD, Unità di Allergologia, Complesso Integrato Columbus, Via G. Moscati, 31, 00168 Rome, Italy; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Romano, Viola, Gaeta, and Valluzzi: Unità di Allergologia, Complesso Integrato Columbus, Via G. Moscati, 31, 00168 Rome, Italy.
Drs. Guéant-Rodriguez and Guéant: INSERM U724, Rue de la Forêt de Haye, 54500, Nancy-Vandoeuvre, France.
Author Contributions: Conception and design: A. Romano, J.-L. Guéant.
Analysis and interpretation of the data: A. Romano, M. Viola, R.-M. Guéant-Rodriguez, F. Gaeta, R. Valluzzi, J.-L. Guéant.
Drafting of the article: A. Romano, M. Viola, R.-M. Guéant-Rodriguez, J.-L. Guéant.
Critical revision of the article for important intellectual content: A. Romano, M. Viola, R.-M. Guéant-Rodriguez, F. Gaeta, R. Valluzzi, J.-L. Guéant.
Final approval of the article: A. Romano, M. Viola, R.-M. Guéant-Rodriguez, F. Gaeta, R. Valluzzi, J.-L. Guéant.
Provision of study materials or patients: A. Romano, M. Viola, F. Gaeta, R. Valluzzi.
Statistical expertise: A. Romano, R.-M. Guéant-Rodriguez, J.-L. Guéant.
Obtaining of funding: A. Romano, J.-L. Guéant.
Administrative, technical, or logistic support: A. Romano.
Collection and assembly of data: A. Romano, J.-L. Guéant.
Although clinicians avoid giving meropenem to patients with penicillin allergy because of potential cross-reactivity, the rate of cross-reactivity between penicillins and meropenem has not been prospectively determined.
To assess the tolerability of meropenem in patients with documented penicillin allergy.
Prospective skin testing and antibiotic challenge.
Allergy units of 2 Italian medical centers.
104 consecutive participants with immediate hypersensitivity reactions to penicillins and positive skin test results to at least 1 penicillin reagent.
Skin tests to meropenem and, if results were negative, challenges with escalating doses of meropenem.
One participant (0.9% [95% CI, 0.02% to 5.2%]) had a positive intradermal test result to meropenem. The remaining 103 participants with negative skin test results to meropenem tolerated escalating dose challenges.
Challenges were not followed by therapeutic courses.
These data indicate a low rate of cross-reactivity between penicillins and meropenem. Therefore, the practice of avoiding meropenem therapy in penicillin-allergic patients should be reconsidered. In patients who especially require meropenem treatment, the authors recommend pretreatment skin tests because negative results indicate tolerability.
Romano A, Viola M, Guéant-Rodriguez R, Gaeta F, Valluzzi R, Guéant J. Brief Communication: Tolerability of Meropenem in Patients with IgE-Mediated Hypersensitivity to Penicillins. Ann Intern Med. ;146:266–269. doi: 10.7326/0003-4819-146-4-200702200-00005
Download citation file:
Published: Ann Intern Med. 2007;146(4):266-269.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use